PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.540.04 (-0.72%)
5.46 - 5.56
4.95 - 8.28
1.3K / 2.4K (Avg.)
-277.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.27%
Revenue growth similar to METSB.HE's 5.27%. Walter Schloss would see if both companies share industry tailwinds.
145.19%
Gross profit growth similar to METSB.HE's 145.19%. Walter Schloss would assume both firms track common industry trends.
543.28%
EBIT growth similar to METSB.HE's 543.28%. Walter Schloss might infer both firms share similar operational efficiencies.
543.28%
Operating income growth similar to METSB.HE's 543.28%. Walter Schloss would assume both share comparable operational structures.
380.33%
Net income growth comparable to METSB.HE's 380.33%. Walter Schloss might see both following similar market or cost trajectories.
411.36%
EPS growth similar to METSB.HE's 411.36%. Walter Schloss would assume both have parallel share structures and profit trends.
411.36%
Similar diluted EPS growth to METSB.HE's 411.36%. Walter Schloss might see standard sector or cyclical influences on both firms.
-6.09%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-6.09%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-56.26%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-83.99%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-14.10%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-15.06%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-9.93%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
572.66%
10Y OCF/share CAGR in line with METSB.HE's 572.66%. Walter Schloss would see both as similarly efficient over the decade.
173.52%
5Y OCF/share CAGR is similar to METSB.HE's 173.52%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
8.39%
3Y OCF/share CAGR similar to METSB.HE's 8.39%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
125.94%
Similar net income/share CAGR to METSB.HE's 125.94%. Walter Schloss would see parallel tailwinds or expansions for both firms.
50.00%
5Y net income/share CAGR similar to METSB.HE's 50.00%. Walter Schloss might see both on parallel mid-term trajectories.
282.40%
3Y net income/share CAGR similar to METSB.HE's 282.40%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
-4.37%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
19.97%
3Y equity/share CAGR similar to METSB.HE's 19.97%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
34.60%
AR growth well above METSB.HE's 34.60%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.72%
Inventory growth well above METSB.HE's 4.72%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.86%
Similar asset growth to METSB.HE's 6.86%. Walter Schloss finds parallel expansions or investment rates.
18.20%
Similar to METSB.HE's 18.20%. Walter Schloss finds parallel capital usage or profit distribution strategies.
0.72%
Debt growth far above METSB.HE's 0.72%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
4.05%
SG&A growth well above METSB.HE's 4.05%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.